Expired activity
Please go to the PowerPak homepage and select a course.

Managing HIV in the New Decade – Are You Treating Like the Experts?

This continuing education activity is provided by

This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.


July 15, 2020


July 14, 2021


Antiretroviral therapy (ART) has improved dramatically over the past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already diverse field of human immunodeficiency virus (HIV) treatment. Clinicians must keep apprised of new data on treatment strategies, including drug simplification and long-acting injectables, selection of appropriate individualized therapy, and effective management of treatment side effects. In this interactive, case-based program, expert faculty will provide guidance on how to incorporate new treatment strategies into clinical practice. They will also discuss various aspects of HIV management, including the selection of an initial antiretroviral regimen for a patient with advanced disease; treatment modification in women; and treatment simplification.

Target Audience

The intended audience for this activity is pharmacists involved in the management of patients with HIV.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Assess the latest clinical evidence regarding the treatment of patients with HIV.
  • Identify patients with HIV who may benefit from switching treatment due to comorbidities and/or side effects.
  • Review the latest evidence regarding emerging long-acting formulations for HIV management.
  • Examine gender issues that may impact choice of ART.
  • Incorporate strategies for optimizing adherence to ARTs in patients with HIV.


Anton Pozniak, MD, FRCP
Consultant Physician
Professor, Clinical Research
Chelsea and Westminster Hospital and LSHTM
London, United Kingdom

Consulting Fee: Gilead, Janssen, Merck, ViiV
Contracted Research: Gilead, Merck

Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts, United States of America

Consulting Fee: Gilead, GlaxoSmithKline/ViiV, Janssen, Merck
Contracted Research: Gilead, GlaxoSmithKline/ViiV, Merck
Editorial Positions: Medscape, NEJM Journal Watch, Open Forum Infectious Diseases, UpToDate


Brenda Crabtree-Ramírez, MD
Assistant Professor
HIV Program at Universidad Nacional Autónoma de México (UNAM)
Infectious Diseases Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, Mexico

Disclosures: No relevant financial relationships to disclose.

Chloe Orkin, MBBCh, FRCP
Consultant Physician Barts Health NHS Trust
Clinical Lead for COVID 19 Research at Barts Health NHS Trust
Lead for HIV and HIV/Hep C Research
Athena Swan Chair, Queen Mary, University of London School of Medicine
London, United Kingdom

Speakers Bureau: Gilead, GlaxoSmithKline, Merck, ViiV
Contracted Research: Gilead, GlaxoSmithKline, Merck, ViiV


Jennifer Cocohoba, PharmD, MAS, BCPS, AAHIVP
Disclosures: No relevant financial relationships to disclose.

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Disclosures: No relevant financial relationships to disclose.

Vindico Medical Education Staff

Disclosures: No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


In accordance with the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears above.


acpe Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Credit Designation

This program is acceptable for 1.0 contact hour of ACPE Continuing Education Credit. The ACPE Universal Program Number 0482-0000-20-004-H02-P, effective 07/15/2020. This is a knowledge-based activity and there is no fee to attend.

This enduring material is approved for 1 year from the date of original release, July 15, 2020 to July 14, 2021.

How to Participate in This Activity and Obtain CME Credit

During the period July 15, 2020 to July 14, 2021, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the posttest and evaluation form directly after the activity within a maximum of 60 days of participating in the activity. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on the Grade Exam button at the bottom of the page. Your posttest will automatically be graded. If you successfully complete the posttest (score of 80% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 80%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.

Educational Tools

For downloadable educational resources, visit below.

For a full list of all the educational tools available through Vindico Medical Education, please visit: www.VindicoCME.com/educationaltools.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CPE Questions?

Contact us at CME@VindicoCME.com